series-a
Stage
1
Investors
About
Sweetch provides an AI- and emotionally-intelligent engagement platform and digital therapeutic that delivers hyper-personalized, just-in-time interventions to improve adherence and outcomes for people with chronic conditions, notably Type 2 diabetes using CGM and patient-reported data. The company partners with healthcare organizations, pharma, device manufacturers and payers to drive behavior change and remote patient monitoring.
Explore Sweetch's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.